Business & Investment

Preview: HUL Q3 PAT up 28%, driven by GSK products. Volume that increases by 3-5%

Mumbai: Hindustan Unileaver expects double-digit net income and revenue growth for the quarter ended Wednesday, supported by a steady recovery in recently acquired products from GSK Consumer Healthcare and certain product segments. ..

HUL’s revenue could increase by 19% year-on-year to rupees. Rs 11,647.8 billion, net profit could rise by 28.4% to Rupees. According to estimates by 12 brokerage firms surveyed by, it is Rs. 20.752 billion.

According to analysts, soap-to-shampoo marker organic revenue is expected to increase by approximately 4.8-6.0%, and the portfolio of products acquired from GSK Consumer Healthcare could record double-digit sales growth.

Analysts expect FMCG companies to report 3-5% organic volume growth in the quarter ended December, suggesting a continued continuous recovery. In the September quarter, the company reported 1% sales growth and 5% growth in the year-ago quarter.

“Winter products are expected to be a driving force HULPerformance during the quarter, led to the beginning of a strong winter. However, the slow recovery in demand for winter commodities limits the benefits of winter commodities, “said the brokerage firm’s antique stockbroker.

Brokerage firms also said their revenue performance was helped by the company’s higher focus on digitizing the supply chain with the “SHIKHAR” application and improved distribution and reach in local markets after the first impact of COVID-19. I’m expecting it.

The company’s operating profit for the quarter is expected to grow at a rate of more than 20% year-on-year. Quarterly 2,929.9 chlores. However, the company’s gross margin may shrink due to the continued increase in raw materials. Last quarter, HUL warned that rising input prices would put pressure on gross profit.

HUL’s operating margin for the December quarter could tend to be 24.3 to 25.0%, as higher input costs are largely balanced by higher tea and soap prices and lower advertising spending.

Brokerage firm Mortal Oswar Securities said investors will focus on management’s commentary on consumer behavior in terms of downtrading, raw material price outlook, and intensifying competition in the sector.

Preview: HUL Q3 PAT up 28%, driven by GSK products. Volume that increases by 3-5% Preview: HUL Q3 PAT up 28%, driven by GSK products. Volume that increases by 3-5%

Back to top button